Pharmacological treatment for Tourette syndrome in children and adults: What is the quality of the evidence? A systematic review.

Besag, Frank Mc; Vasey, Michael J; Lao, Kim Sj; Chowdhury, Uttom; Stern, Jeremy S

Besag, Frank Mc; Vasey, Michael J; Lao, Kim Sj; Chowdhury, Uttom; Stern, Jeremy S.

Affiliation

Besag FM; East London NHS Foundation Trust, Bedford, UK.
Vasey MJ; University College London, London, UK.
Lao KS; King's College London, UK.
Chowdhury U; University College London, London, UK.
Stern JS; Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong.

J Psychopharmacol ; 35(9): 1037-1061, 2021 Sep.

Article in En | MEDLINE | ID: mdl-34286606

Subject(s)

Antipsychotic Agents/administration & dosage; Tourette Syndrome/drug therapy; Adult; Age Factors; Antipsychotic Agents/adverse effects; Child; Humans; Patient Acuity; Randomized Controlled Trials as Topic; Research Design; Tourette Syndrome/physiopathology; Treatment Outcome

Key words

Tourette syndrome; alpha-2 agonist; antipsychotic; aripiprazole; clonidine; efficacy; guanfacine; haloperidol; pharmacotherapy; pimozide; risperidone; safety; sulpiride; tiapride

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antipsychotic Agents / Tourette Syndrome Type of study: Clinical_trials / Prognostic_studies / Systematic_reviews Limits: Adult / Child / Humans Language: En Journal: J Psychopharmacol Journal subject: PSICOFARMACOLOGIA Year: 2021 Type: Article Affiliation country: United kingdom

Fulltext

XML

PubMed Links

Search on Google